PharmacoEconomics & Outcomes News

, Volume 799, Issue 1, pp 2–2 | Cite as

ICER finds emicizumab offers improvements for haemophilia A

News item


  1. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Finds Emicizumab Reduces Treatment Cost While Improving Health of People with Hemophilia A. Internet Document : 15 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations